Momentum remains strong across MedTech as investors support companies developing advanced solutions in stroke intervention, robotics, and digital diagnostics. This week’s deals reflect a focus on technologies nearing clinical and commercial inflection points.
Imperative Care secures $100M to commericalize its stroke care tech
The company plans to use the proceeds to support the continued commercialization of its stroke and vascular thrombectomy portfolios. It also plans to use funds to invest in next-generation technology and new product development.
New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing in partnership with existing investor Catalio Capital Management.
CEO Fred Khosravi
Last week’s tracker: Vitestro, Neuros & more
Thrombolex secures a $50M Series A equity financing
The financing strengthens its capital position as it expands its United States commercial infrastructure and advances the generation of clinical evidence across its endovascular catheter platform.
The $50M Series A equity financing was led by OrbiMed and supported by current investors and cofounders.
President and CEO Michael Cerminaro
Monteris Medical raises $28M Series E for robotic neurosurgery tech
The equity capital will support research and development and other growth initiatives, while the equity financing will back U.S. commercial footprint expansion and accelerate other growth initiatives.
The new investments bring Monteris’ total money raised around $200M. The company also announced that it has refinanced its current debt and established a new $35 million credit facility with Trinity Capital.
CEO Marty Emerson
Bioliberty raises $10.2M to build functional intelligence capabilities
The funds will enable the company to continue the development and U.S. commercialization of its transformative Lifehub Clinic platform, which will incorporate new computer vision and care coordination capabilities.
The financing will also enable the commercialization of Lifehub Home to facilitate ongoing physical therapy and progress tracking in patient homes after in-person therapy ends.
Co-Founder and CEO Rowan Armstrong
Carecubes closes a $6.5M Series A funding round
The Series A marks a major milestone toward Carecubes’ mission of eliminating infectious disease transmission in healthcare settings.
The Carecube was initially funded by the Defense Advanced Research Projects Agency (DARPA) and further supported by the Centers for Disease Control and Prevention (CDC) and the Administration for Strategic Preparedness and Response (ASPR).
CEO Alex Laskey
HEARTio secures $4.25M to advance ECGio AI platform
The company will use the fresh capital to launch its pivotal study, which is the critical final step in seeking FDA clearance for the technology.
Backers include Intelligence Ventures, Audacious Capital, VU Venture Partners, LifeX, and Bessel.
CEO Utkars Jain
MedicQuant raises DKK 22M to advance technology for acute stroke treatment
The first close of its seed round was led by Delphinus Venture Capital with participation from a group of business angels and follow-on investment from existing investors, including the Export and Investment Fund of Denmark.
With the new investment, the spinout now enters its next phase, focusing on completing product development, advancing clinical studies and preparing for market entry.
Co-Founder and CEO Line Debois
Dentronic secures $1M in pre-seed funding
The financing was supported by South Park Commons, with Crew Capital also backing the round, to automate the repetitive chairside tasks that still leave clinics dependent on scarce assistants.
The investment underscores confidence in Dentronic’s approach to enhancing surgical procedures through advanced technology.
Co-Founders Soy Choi, Sam Lee, and Kenneth Choi
Rymo Technologies secures ₹10 Crore in seed round
The proceeds will be used to accelerate product innovation, expand manufacturing capabilities, and strengthen the company’s presence across India, while also scaling into international markets, including ASEAN and the Middle East, Rymo Technologies said in a press release.
The funding round was led by IAN Group through its evergreen fund, along with participation from other angel investors.
Co-Founder and CEO Chirag Shah
WallabyPhenox restructures debt and accelerates global growth
The company announced the successful completion of a significant financing round aimed at strengthening its financial foundation.
The deal was led by Yunfeng Capital, HJ Partners, Gaorong Venture, Junsong Capital, and Qianhai Ark Asset Management, with participation from Enlight Medical.
Founder and President Michael Alper
